ANGIODYNAMICS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by AngioDynamics, Inc. on August 2, 2004, with a report date of July 29, 2004. The filing announces a conference call held to discuss financial results for the three months and 12 months ended May 29, 2004, and to provide guidance for future periods.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached conference call transcript (Exhibit 99.1) rather than the body of this Form 8-K.
Material Changes
The filing does not detail specific material changes versus prior periods. It serves as a notification that results for the period ended May 29, 2004, have been discussed and are available in the referenced transcript.
Guidance, Outlook, and Risks
Management provided guidance for future periods during the July 29, 2004 conference call. The filing explicitly states that the information contained herein and in the attached exhibit is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Transcript of conference call) for specific financial results and guidance figures.
- Verify the exact revenue and earnings per share for the three and twelve months ended May 29, 2004.
- Confirm the specific forward-looking guidance provided by management during the call.
- Check subsequent filings for any updates to the financial data discussed in this report.